MYO1F regulates antifungal immunity by regulating acetylation of microtubules

Proc Natl Acad Sci U S A. 2021 Jul 27;118(30):e2100230118. doi: 10.1073/pnas.2100230118.

Abstract

Opportunistic fungal infections have become one of the leading causes of death among immunocompromised patients, resulting in an estimated 1.5 million deaths each year worldwide. The molecular mechanisms that promote host defense against fungal infections remain elusive. Here, we find that Myosin IF (MYO1F), an unconventional myosin, promotes the expression of genes that are critical for antifungal innate immune signaling and proinflammatory responses. Mechanistically, MYO1F is required for dectin-induced α-tubulin acetylation, acting as an adaptor that recruits both the adaptor AP2A1 and α-tubulin N-acetyltransferase 1 to α-tubulin; in turn, these events control the membrane-to-cytoplasm trafficking of spleen tyrosine kinase and caspase recruitment domain-containing protein 9 Myo1f-deficient mice are more susceptible than their wild-type counterparts to the lethal sequelae of systemic infection with Candida albicans Notably, administration of Sirt2 deacetylase inhibitors, namely AGK2, AK-1, or AK-7, significantly increases the dectin-induced expression of proinflammatory genes in mouse bone marrow-derived macrophages and microglia, thereby protecting mice from both systemic and central nervous system C. albicans infections. AGK2 also promotes proinflammatory gene expression in human peripheral blood mononuclear cells after Dectin stimulation. Taken together, our findings describe a key role for MYO1F in promoting antifungal immunity by regulating the acetylation of α-tubulin and microtubules, and our findings suggest that Sirt2 deacetylase inhibitors may be developed as potential drugs for the treatment of fungal infections.

Keywords: MYO1F; Sirt2 inhibitor; antifungal immunity; microtubules acylation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylation
  • Animals
  • Antifungal Agents / pharmacology
  • Candida albicans / physiology*
  • Candidiasis / drug therapy
  • Candidiasis / immunology*
  • Candidiasis / metabolism
  • Candidiasis / microbiology
  • Humans
  • Immunity, Innate / immunology*
  • Leukocytes, Mononuclear / drug effects
  • Leukocytes, Mononuclear / immunology*
  • Leukocytes, Mononuclear / metabolism
  • Leukocytes, Mononuclear / microbiology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Microtubules / drug effects
  • Microtubules / immunology*
  • Microtubules / metabolism
  • Microtubules / microbiology
  • Myosin Type I / genetics
  • Myosin Type I / metabolism*
  • Myosin Type I / physiology*
  • Signal Transduction

Substances

  • Antifungal Agents
  • MYO1F protein, human
  • Myo1f protein, mouse
  • Myosin Type I